The results of the SPT indicated that depression-like behavior induced by oral ciprofloxacin was affected by serotonin levels in the hippocampus and serotonin, cortisol, and NF-κB levels in the prefrontal cortex area. Here, NFKB1 is linked to depressive symptom measurement.